Theriva Biologics Inc (TOVX) Live Share Price, Invest From India

Theriva Biologics Inc Stock Performance

as on October 28, 2025 at 1:29 am IST

Day's Low
Day's High
$0.3
Day's Price Range
$0.34
$0.32
6.25%
Downside
6.25%
Upside
52 Week's Low
52 Week's High
$0.28
52-Week Price Range
$2.64
$0.32
11.56%
Downside
725.00%
Upside

Theriva Biologics Inc share price movements today

Previous Close: $0.34
Open: $0.34
Volume: 14.4M
Day's Low - High: $0.3 - $0.34
52 Week Low - High: $0.28 - $2.64

Theriva Biologics Inc Historical Returns

1 Month Return: -17.48 %
3 Month Return: -32.03 %
1 Year Return: -78.45 %
3 Year Return: -98.28 %
5 Year Return: 0 %

Theriva Biologics Inc Stock Fundamentals & Key Indicators

Check Theriva Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1M

EPS (TTM)

-2.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-26.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-154.45%

Theriva Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Theriva Biologics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Theriva Biologics Inc	BUY	$6.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.7B	283.23%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$108.0B	101.68%	29.95	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	3.22%	14.55	31.37%

Stock Returns calculator for Theriva Biologics Inc Stock including INR - Dollar returns

The Theriva Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Theriva Biologics Inc investment value today

Current value as on today

₹26,184

Returns

₹73,816

(-73.82%)

Returns from Theriva Biologics Inc Stock

₹78,947 (-78.95%)

Dollar Returns*

₹5,132 (+5.13%)

Analyst Recommendation on Theriva Biologics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Theriva Biologics Inc. Average target price of $7

Theriva Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on Theriva Biologics Inc.

What analysts predicted

95.43%UPSIDE

Target Price

Current Price

$0.32

Analyzed by

8 Analysts

Target

$7.00

Theriva Biologics Inc target price $7, a slight upside of 95.43% compared to current price of $0.32. According to 8 analysts rating.

Theriva Biologics Inc Stock’s Investor Sentiment and Interest

Investment in Theriva Biologics Inc Shares on INDmoney has grown by 2471.42% over the past 30 days, indicating increased transactional activity.

Time period: September 28, 2025 to October 28, 2025

Change:2471.42% versus previous 30 day period

Search interest for Theriva Biologics Inc Stock has increased by 576% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 28, 2025 to October 28, 2025

Change:576% versus previous 30 day period

Theriva Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-5	-4	-5	-5	-8	-7	-4	-4	-3
EBITDA	-5	-5	-5	-5	-5	-4	-5	-10	-4	-13
Interest Expense	0	-	-	0	-	-	-	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-3	-5	-5	-8	-7	-4	-4	-13
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-4	-5	-3	-5	-5	-8	-7	-4	-4	-13
Net Profit Margin	0.00%	0.00%	0.00%	-723.61%	0.00%	0.00%	0.00%	-2887.66%	0.00%	0.00%

Theriva Biologics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-17	-15	-10	-14	-21	-21	-18
EBITDA	-17	-15	-9	-14	-19	-19	-25
Interest Expense	-	-	-	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-13	-15	-10	-14	-21	-19	-25
Income Tax Expense	-4	0	0	0	-1	-1	-
Net Income	-13	-15	-9	-14	-19	-18	-25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Theriva Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-3	-5	-5	-8	-7	-4	-4	-13
Operating Cash Flow	-3	-2	-6	-4	-3	-3	-4	-4	-4
Investing Cash Flow	0	0	0	-	0	-	-	-	0
Financing Cash Flow	2	0	-1	-	1	3	0	3	6
Change in Cash	-1	-3	-7	-4	-1	0	-4	-1	2

Theriva Biologics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-27	-15	-13	-15	-10	-14	-19	-18	-25
Operating Cash Flow	-27	-20	-17	-13	-12	-12	-19	-18	-16
Investing Cash Flow	0	0	0	0	0	0	-4	0	0
Financing Cash Flow	26	18	29	3	3	74	-1	0	5
Change in Cash	-1	-1	11	-13	-8	61	-25	-18	-11

Insights on Theriva Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TOVX stock has moved up by 9.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 232.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.8% return, outperforming this stock by 145.2%

About Theriva Biologics Inc

synthetic biologics, inc. (nyse mkt: syn) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. the company's lead candidates poised for phase 3 development are: (1) syn-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (ibs-c), and (2) syn-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (iv) beta-lactam antibiotics for the prevention of c. difficile infection (cdi), antibiotic-associated diarrhea (aad) and the emergence of antimicrobial-resistance (amr). the company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (pku).

Organisation	Theriva Biologics Inc
Headquarters	9605 Medical Center Drive, Rockville, MD, United States, 20850
CEO	Mr. Steven A. Shallcross CPA
E-voting on shares	Click here to vote

Key Management of Theriva Biologics Inc

Name	Title
Dr. Michael Kaleko M.D., Ph.D.	Senior Vice President of Research & Development
Dr. Ramon Alemany Ph.D.	Senior Vice President of Discovery
Mr. Steven A. Shallcross CPA	CEO, CFO, Treasurer, Corporate Secretary & Director
Dr. Vince Wacher Ph.D.	Head of Product & Corporate Development

FAQs

What is Theriva Biologics Inc share price today?

Theriva Biologics Inc share price today is $0.32 as on October 28, 2025 at 1:29 am IST at the close of the market. Theriva Biologics Inc share today touched a day high of $0.34 and a low of $0.3.

What is the 52 week high and 52 week low for Theriva Biologics Inc share?

Theriva Biologics Inc share touched a 52 week high of $2.64 on November 1, 2024 and a 52 week low of $0.28 on October 22, 2025. Theriva Biologics Inc stock price today i.e. October 28, 2025 at 1:29 am IST is closed at $0.32,which is 87.88% down from its 52 week high and 13.07% up from its 52 week low.

What is Theriva Biologics Inc's market capitalisation today?

Theriva Biologics Inc market capitalisation is $0.00T as on October 28, 2025 at 1:29 am IST.

How to invest in Theriva Biologics Inc Stock (TOVX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Theriva Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theriva Biologics Inc Shares that will get you 4.6875 shares as per Theriva Biologics Inc share price of $0.32 per share as on October 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Theriva Biologics Inc Stock (TOVX) from India?

Indian investors can start investing in Theriva Biologics Inc (TOVX) shares with as little as ₹88.237 or $1 (as of October 28, 2025 at 4:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Theriva Biologics Inc stock (as per the Rupee-Dollar exchange rate as on October 28, 2025 at 4:43 pm IST). Based on Theriva Biologics Inc share’s latest price of $0.32 as on October 28, 2025 at 1:29 am IST, you will get 31.2500 shares of Theriva Biologics Inc. Learn more about fractional shares .